Detalhe da pesquisa
1.
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.
Blood
; 143(21): 2152-2165, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437725
2.
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study.
Clin Pharmacol Ther
; 113(4): 851-858, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606486
3.
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.
CPT Pharmacometrics Syst Pharmacol
; 12(11): 1738-1750, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165943
4.
Bayesian forecasting of tumor size metrics and overall survival.
CPT Pharmacometrics Syst Pharmacol
; 11(12): 1604-1613, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194478
5.
Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel.
CPT Pharmacometrics Syst Pharmacol
; 10(5): 511-521, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818899
6.
Multistate model for pharmacometric analyses of overall survival in HER2-negative breast cancer patients treated with docetaxel.
CPT Pharmacometrics Syst Pharmacol
; 10(10): 1255-1266, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313026
7.
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors.
Clin Cancer Res
; 26(17): 4590-4598, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522885